MedPath

Coeruleus Ltd.

🇮🇱Israel
Ownership
Private
Employees
-
Market Cap
-
Website
http://www.coeruleus.com

Clinical Trials

2

Active:0
Completed:2

Trial Phases

1 Phases

Phase 1:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 1
2 (100.0%)

Safety and Pharmacokinetic Study of Sublingual Flumazenil (CRLS035) in Healthy Adults

Phase 1
Completed
Conditions
Insomnia
Interventions
First Posted Date
2012-08-02
Last Posted Date
2015-01-30
Lead Sponsor
Coeruleus Ltd.
Target Recruit Count
10
Registration Number
NCT01655914
Locations
🇮🇱

Rambam Health Care Campus, Haifa, Israel

Safety and the Efficacy of a Sublingual Administration of Flumazenil to Reverse the Effect of Hypnotic Drugs in Healthy Adults

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Placebo
First Posted Date
2010-02-19
Last Posted Date
2015-01-30
Lead Sponsor
Coeruleus Ltd.
Target Recruit Count
10
Registration Number
NCT01071889
Locations
🇮🇱

Rambam Medical Center, Haifa, Israel

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.